Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference42 articles.
1. Esterhay Jr RJ, Wiernik PH, Grove WR, et al. Moderate dose methotrexate, vincristine, asparaginase, and dexamethasone for treatment of adult acute lymphocytic leukemia. Blood. 1982;59:334–45.
2. Wiernik PH, Dutcher JP, Paietta E, et al. Long-term follow-up of treatment and potential cure of adult acute lymphocytic lkeukemia with MOAD: a non-anthracycline containing regimen. Leukemia. 1993;7:1236–41.
3. Hui L, Wiernik PH. Avascular necrosis of bone after adult acute lymphocytic leukemia treatment with methotrexate, vinvristine, L-asparaginase, and dexamethasone (MOAD). Am J Hematol. 1996;52:184–8.
4. Wiernik PH, Cassileth PA, Leong T, et al. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone cytarabine and 6-thioguanine) in acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group study (E3486). Leuk Lymphoma. 2003;44:1515–21.
5. Morris K, Weston H, Mollee P, et al. Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionation cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: results from an Australian population. Leuk Lymphoma. 2011;52:85–91.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献